Pandya Pooja G, Kim T Edward, Howard Steven K, Stary Erica, Leng Jody C, Hunter Oluwatobi O, Mariano Edward R
Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Palo Alto, CA, USA.
Anesthesiology and Perioperative Care Service, Veterans Affairs Palo Alto Health Care System, Palo Alto, CA, USA.
Korean J Anesthesiol. 2017 Aug;70(4):439-445. doi: 10.4097/kjae.2017.70.4.439. Epub 2017 Mar 15.
Virtual reality (VR) distraction is a nonpharmacological method to prevent acute pain that has not yet been thoroughly explored for anesthesiology. We present our experience using VR distraction to decrease routine intravenous sedation for patients undergoing preoperative perineural catheter insertion.
This 1-month quality improvement project involved all elective unilateral primary total knee arthroplasty patients who received a preoperative adductor canal catheter. Clinical data were analyzed retrospectively. For the first half of the month, all patients received usual care; intravenous sedation was administered at the discretion of the regional anesthesiologist. For the second half of the month, patients were offered VR distraction with intravenous sedation upon request. The primary outcome was fentanyl dosage; other outcomes included midazolam dosage, procedure-related pain, procedural time, and blood pressure changes.
Seven patients received usual care and seven used VR. In the VR group, 1/7 received intravenous sedation versus 6/7 who received usual care (P = 0.029). The fentanyl dose was lower (median [10th-90th percentiles]) in the VR group (0 [0-20] µg) versus the non-VR group (50 [30-100] µg; P = 0.008). Midazolam use was lower in the VR group (0 [0-0] mg) than in the non-VR group (1 [0-1] mg; P = 0.024). Procedure-related pain was lower in the VR group (1 [1-4] NRS) versus the non-VR group (3 [2-6] NRS; P = 0.032). There was no difference in other outcomes.
VR distraction may provide an effective nonpharmacological alternative to intravenous sedation for the ultrasound-guided placement of certain perineural catheters.
虚拟现实(VR)分散注意力是一种预防急性疼痛的非药物方法,麻醉学领域尚未对其进行充分探索。我们介绍了使用VR分散注意力来减少接受术前神经周围导管插入术患者的常规静脉镇静的经验。
这个为期1个月的质量改进项目纳入了所有接受术前内收肌管导管插入术的择期单侧初次全膝关节置换术患者。对临床数据进行回顾性分析。在该月的上半月,所有患者接受常规护理;静脉镇静由区域麻醉医生酌情给予。在该月的下半月,患者可根据需要接受VR分散注意力并同时接受静脉镇静。主要结局是芬太尼剂量;其他结局包括咪达唑仑剂量、与手术相关的疼痛、手术时间和血压变化。
7名患者接受常规护理,7名使用VR。在VR组中,1/7接受静脉镇静,而接受常规护理的患者为6/7(P = 0.029)。VR组的芬太尼剂量较低(中位数[第10 - 90百分位数]),为0(0 - 20)μg,而非VR组为50(30 - 100)μg;P = 0.008。VR组咪达唑仑的使用量低于非VR组,分别为0(0 - 0)mg和1(0 - 1)mg;P = 0.024。VR组与手术相关的疼痛较低,数字评分量表(NRS)评分为1(1 - 4),而非VR组为3(2 - 6);P = 0.032。其他结局无差异。
对于超声引导下放置某些神经周围导管,VR分散注意力可能为静脉镇静提供一种有效的非药物替代方法。